Healthcare -
Biotechnology - NASDAQ - US
$ 0.5265
-0.66 %
$ 37.4 M
Market Cap
-1.14
P/E
OVID - STOCK-BASED COMPENSATION
Stock-based Compensation OVID - Ovid Therapeutics Inc.
7.29 M
LAST VALUE
20.06%
2 YEAR CAGR
0.62%
5 YEAR CAGR
0.00%
10 YEAR CAGR